Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease

American Heart Journal

Volumn 154, Issue 6, 2007, Pages 1043-1051

  Hlatky, Mark A ^a   Ashley, Euan ^a   Quertermous, Thomas ^a   Boothroyd, Derek B ^a   Ridker, Paul ^b   Southwick, Audrey ^a   Myers, Richard M ^a   Iribarren, Carlos ^c   Fortmann, Stephen P ^a   Go, Alan S ^c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN; STROMELYSIN 2;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY RISK; ENZYME BLOOD LEVEL; ENZYME POLYMORPHISM; FEMALE; GENE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MMP1 GENE; MMP10 GENE; MMP2 GENE; MMP3 GENE; MMP9 GENE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY ARTERY DISEASE; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36148996890     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.042     Document Type: Article

References (25)

1. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. Circ Res 92 (2003) 827-839
2. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis. The good, the bad, and the ugly. Circ Res 90 (2002) 251-262
3. Tayebjee M.H., Lip G.Y.H., Tan K.T., et al. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 96 (2005) 339-345
4. Zeng B., Prasan A., Fung K.C., et al. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease. Intern Med J 35 (2005) 331-335
5. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32 (1998) 368-372
6. Inoue T., Kato T., Takayanagi K., et al. Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome. Am J Cardiol 92 (2003) 1461-1464
7. Blankenberg S., Rupprecht H.J., Poirier O., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107 (2003) 1579-1585
8. Beyzade S., Zhang S., Wong Y., et al. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 41 (2003) 2130-2137
9. Terashima M., Akita H., Kanazawa K., et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 99 (1999) 2717-2719
10. Ye S., Watts G.F., Maldalia S., et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73 (1995) 209-215
11. Humphries S.E., Luong L.A., Talmud P.J., et al. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Atherosclerosis 139 (1998) 49-56
12. de Maat M.P.M., Jukema J.W., Ye S., et al. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol 83 (1999) 852-856
13. Zhang B., Ye S., Herrmann S.M., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
14. Morgan A.R., Zhang B., Tapper W., et al. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med 81 (2003) 321-326
15. Pöllänen P.J., Karhunen P.J., Mikkelsson J., et al. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene. An autopsy study. Arterioscler Thromb Vasc Biol 21 (2001) 1446-1450
16. Pearce E., Tregouet D.A., Samnegård A., et al. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 97 (2005) 1070-1076
17. Vašku, Goldbergová M., Hollá L.I., et al. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease. Matrix Biol 22 (2004) 585-591
18. Go A.S., Iribarren C., Chandra M., et al. Statin and b-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med 144 (2006) 229-238
19. Tabor H.K., Risch N.J., and Myers R.M. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3 (2002) 391-397
20. R Development Core Team. R: A language and environment for statistical computing (2006), ISBN R Foundation for Statistical Computing. 3-900051-07-0. http://www.R-project.org
21. Kaden J.J., Dempfle C., Sueselbeck T., et al. Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction. Cardiology 99 (2003) 140-144
22. Galis Z.S., Sukhova G.K., Lark M.W., et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94 (1994) 2493-2503
23. Orbe J., Fernandez L., Rodriguez J.A., et al. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis 170 (2003) 269-276
24. Sakai Y., Tsunoda K., Ishibashi I., et al. Time course of left ventricular remodeling after myocardial infarction: a two-dimensional echocardiographic study. Jpn Circ J 64 (2000) 421-429
25. Zhang B., Henney A., Eriksson P., et al. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105 (1999) 418-423